| Literature DB >> 34027327 |
Robert Paul1,2, Torie Tsuei3, Kyu Cho1, Andrew Belden1, Benedetta Milanini3, Jacob Bolzenius1, Shireen Javandel3, Joseph McBride1, Lucette Cysique4, Samantha Lesinski1, Victor Valcour3,5.
Abstract
BACKGROUND: clinically relevant methods to identify individuals at risk for impaired daily living abilities secondary to neurocognitive impairment (ADLs) remain elusive. This is especially true for complex clinical conditions such as HIV-Associated Neurocognitive Disorders (HAND). The aim of this study was to identify novel and modifiable factors that have potential to improve diagnostic accuracy of ADL risk, with the long-term goal of guiding future interventions to minimize ADL disruption.Entities:
Keywords: ADLs; Aging; HIV; Machine learning
Year: 2021 PMID: 34027327 PMCID: PMC8129893 DOI: 10.1016/j.eclinm.2021.100845
Source DB: PubMed Journal: EClinicalMedicine ISSN: 2589-5370
Sociodemographic and clinical characteristics for the total sample, by race, and by ADL subgroup status.
| Total Sample ( | White Participants ( | Black Participants ( | Non-White/ Non-Black ( | ADL Non-Risk ( | ADL Risk Group ( | |
|---|---|---|---|---|---|---|
| Age in years: Mean (SD) | 63·1 (5·1) | 63·3 (4·9) | 64·1 (5·9) | 59·7 (3·7) | 64·3 (5·1) | 61·9 (4·8) |
| Education in years: Mean (SD) | 15·8 (2·5) | 16·3 (2·3) | 14·5 (2·4) | 13·7 (2·1) | 16·5 (2·5) | 15·0 (2·2) |
| % Male | 95% | 98% | 77% | 100% | 95% | 95% |
| % MSM | 79% | 88% | 31% | 86% | 83% | 74% |
| Nadir CD4 T-cell count: Median (IQR) | 183 (219) | 180 (159) | 217 (296) | 100 (288) | 199 (176) | 128 (262) |
| Current CD4+ | 620 (382) | 578 (321) | 731 (555) | 781 (902) | 643 (333) | 540 (438) |
| Plasma HIV RNA suppression | 100% | 100% | 100% | 100% | 100% | 100% |
| WRAT-4 T-score: Mean (SD) | 50 (10) | 51·50 (8·86) | 42 (14·98) | 48·81 (2·43) | 52·8 (9·9) | 46·7 (9·2) |
| Geriatric Depression Scale: Mean (SD) | 9·4 (6·3) | 9·9 (6·7) | 7·8 (6·0) | 9·0 (4·0) | 9·5 (6·1) | 9·4 (6·7) |
MSM = Men who have sex with men. SD = Standard deviation. IQR = Interquartile Range. One participant reported a history of learning difficulty, and one participant reported current use of an opioid medication for chronic pain. Non-White/Non-Black subgroup was comprised of the following: Native Hawaiian or Pacific Islander (n = 2), Asian (n = 1), and (n = 4) endorsed “other”.
Fig. 1Predictors of ADL risk groups defined by the univariate and interactive GBM models.
Fig. 2Directionality of predictors of NAB-DLM ADL risk subgroup.
Fig. 3Ridgeline plot displaying distributions of NAB-DLM raw and T-scores by race.
NAB-DLM T-scores for the total sample, by race and by ADL subgroup status.
| Total Sample ( | White Participants ( | Black Participants ( | Non-White/ Non-Black ( | ADL Non-Risk ( | ADL Risk Group ( | |
|---|---|---|---|---|---|---|
| Daily Living Memory Immediate Recall | 46·77 (9·36) | 48·49 (8·31) | 41·31 (12·02) | 42·43 (8·26) | 52·08 (7·36) | 41·33 (8·03) |
| Daily Living Memory Delayed Recall | 43·91 (11·96) | 45·81 (11·75) | 36·00 (9·43) | 42·57 (13·15) | 50·25 (10·60) | 37·41 (9·62) |
| Bill Payment | 45·66 (10·53) | 48·02 (8·49) | 35·54 (12·99) | 34·01 (11·41) | 50·28 (6·11) | 40·92 (11·99) |
| Judgment | 50·28 (11·44) | 52·58 (11·25) | 43·08 (8·77) | 44·29 (10·80) | 56·08 (10·73) | 44·33 (8·88) |
| Map Reading | 44·54 (9·03) | 45·19 (8·78) | 42·46 (10·49) | 43·00 (8·87) | 47·28 (9·44) | 41·74 (7·75) |
| Driving Scenes | 44·95 (8·42) | 45·81 (8·03) | 42·15 (9·55) | 42·86 (9·34) | 48·90 (7·69) | 40·90 (7·17) |
| Overall NAB-DLM score | 46·02 (5·93) | 47·65 (5·10) | 40·09 (6·40) | 43·29 (3·60) | 50·81 (3·19) | 41·11 (3·57) |
Average T-score below clinical threshold for impairment (T<40).